While Pillar5 Pharma Inc. is a new company, the Arnprior, Ontario manufacturing facility was established in 1956 by Pfizer Canada Inc. and acquired recently by Pillar5. With nearly 100 employees, the facility has a long-standing record of manufacturing quality product for the pharmaceutical industry and “a foundation of excellence”.
With millions of dollars in investment over the past many years, the Arnprior manufacturing facility is equipped with state-of-the-art equipment, infrastructure and processes, along with proven expertise in the manufacturing and packaging of oral solid and sterile ophthalmic products.
Pillar5 remains committed to quality and lean principles. We strive to deliver your important products on time, every time. Just as important, we are only a phone call away and will always consider options and alternatives to better serve your changing needs. We are committed to your success.
Pillar5 Pharma strives to manage complexity for our customers by offering the following solutions:
- Supporting development programs for innovative products to enhance speed to market
- Helping to increase value in mature products
- Developing a strategy to provide small volume sterile ophthalmic at effective cost